Embellence Group Future Growth
Future criteria checks 1/6
Embellence Group is forecast to grow earnings and revenue by 18.6% and 5% per annum respectively. EPS is expected to grow by 18.6% per annum. Return on equity is forecast to be 12.8% in 3 years.
Key information
18.6%
Earnings growth rate
18.6%
EPS growth rate
Consumer Durables earnings growth | 18.3% |
Revenue growth rate | 5.0% |
Future return on equity | 12.8% |
Analyst coverage | Low |
Last updated | 08 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 871 | 74 | 99 | 115 | 1 |
12/31/2025 | 827 | 66 | 94 | 108 | 1 |
12/31/2024 | 792 | 56 | 71 | 88 | 1 |
3/31/2024 | 757 | 43 | 59 | 77 | N/A |
12/31/2023 | 740 | 39 | 49 | 65 | N/A |
9/30/2023 | 728 | 34 | 26 | 44 | N/A |
6/30/2023 | 713 | 41 | 44 | 59 | N/A |
3/31/2023 | 733 | 46 | 57 | 73 | N/A |
12/31/2022 | 720 | 57 | 93 | 108 | N/A |
9/30/2022 | 717 | 66 | 89 | 107 | N/A |
6/30/2022 | 684 | 57 | 77 | 95 | N/A |
3/31/2022 | 654 | 69 | 68 | 86 | N/A |
12/31/2021 | 647 | 59 | 44 | 62 | N/A |
9/30/2021 | 639 | 55 | 53 | 66 | N/A |
6/30/2021 | 634 | 57 | 55 | 69 | N/A |
3/31/2021 | 595 | 55 | 67 | 80 | N/A |
12/31/2020 | 570 | 48 | 50 | 67 | N/A |
12/31/2019 | 594 | 50 | 38 | 51 | N/A |
12/31/2018 | 569 | 49 | 28 | 42 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9P7's forecast earnings growth (18.6% per year) is above the savings rate (0.7%).
Earnings vs Market: 9P7's earnings (18.6% per year) are forecast to grow slower than the German market (18.7% per year).
High Growth Earnings: 9P7's earnings are forecast to grow, but not significantly.
Revenue vs Market: 9P7's revenue (5% per year) is forecast to grow slower than the German market (5.1% per year).
High Growth Revenue: 9P7's revenue (5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9P7's Return on Equity is forecast to be low in 3 years time (12.8%).